Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
23.63
+1.44 (6.49%)
At close: Dec 5, 2025, 4:00 PM EST
23.23
-0.40 (-1.69%)
After-hours: Dec 5, 2025, 7:59 PM EST
Apellis Pharmaceuticals (APLS) Revenue by Segment
History
| Date | Collaboration License and Other | Product |
|---|---|---|
| Sep 30, 2025 | 326.18M | 690.21M |
| Jun 30, 2025 | 65.62M | 689.03M |
| Mar 31, 2025 | 79.06M | 696.78M |
| Dec 31, 2024 | 71.41M | 709.95M |
| Sep 30, 2024 | 57.78M | 657.44M |
| Jun 30, 2024 | 48.74M | 580.05M |
| Mar 31, 2024 | 33.51M | 490.56M |
| Dec 31, 2023 | 30.31M | 366.28M |
| Sep 30, 2023 | 25.60M | 247.28M |
| Jun 30, 2023 | 18.76M | 165.77M |
| Mar 31, 2023 | 14.10M | 91.78M |
| Dec 31, 2022 | 10.33M | 65.09M |
| Sep 30, 2022 | 58.40M | 54.65M |
| Jun 30, 2022 | 54.36M | 42.29M |
| Mar 31, 2022 | 303.69M | 27.26M |
| Dec 31, 2021 | 302.06M | 15.77M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.